| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K16147474 |
| PharmacoGx | BRD-K16147474 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPRKB | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | EPOR | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | GATA2 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.07 |
| mRNA | PEX26 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.07 |
| mRNA | MZT1 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | HS1BP3 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.07 |
| mRNA | CUL2 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.07 |
| mRNA | EXD2 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.07 |
| mRNA | PSMD7 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | PSMA7 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.07 |
